Nottingham University Hospitals; QMC Campus

Nottingham NG7 2UH

0 studies enrolling now · 3 studies all time

What they study most

Malignant Melanoma, Ulcerative Colitis

Studies at this site

• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma — Completed
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors — Completed